ORI CAPITAL
ORI Healthcare Fund L.P. is a US$200 million venture capital fund focused on investing in innovative companies with disruptive technologies in the healthcare industry globally. The fund is founded by Ms. Simone Song, former investment banker and head of China Healthcare at Goldman Sachs. The team consists mostly of former Goldman Sachs bankers and healthcare scientists. The Fund is supported by a network of most renowned scientists, practitioners and entrepreneurs.
ORI CAPITAL
Industry:
Health Care
Founded:
2015-01-01
Status:
Active
Contact:
+852 3898 1500
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Apache Organization Schema JsDelivr Cloudflare JS CDN JS
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-07 | AffyImmune Therapeutics | ORI Capital investment in Series A - AffyImmune Therapeutics | 20 M USD |
| 2020-12-10 | CG Oncology | ORI Capital investment in Series D - CG Oncology | 47 M USD |
| 2020-05-12 | Pillar Biosciences | ORI Capital investment in Series C - Pillar Biosciences | 29.7 M USD |
| 2019-03-18 | CG Oncology | ORI Capital investment in Series C - CG Oncology | 22 M USD |
| 2018-10-25 | Enable Injections | ORI Capital investment in Series B - Enable Injections | 50 M USD |
| 2017-12-20 | Orchard Therapeutics | ORI Capital investment in Series B - Orchard Therapeutics | 110 M USD |
| 2017-11-29 | Semma Therapeutics | ORI Capital investment in Series B - Semma Therapeutics | 114 M USD |
| 2017-11-15 | Arterys | ORI Capital investment in Series B - Arterys | 30 M USD |
| 2017-03-03 | TriSalus Life Sciences | ORI Capital investment in Series D - TriSalus Life Sciences | 12.8 M USD |
| 2016-11-24 | Kymab | ORI Capital investment in Series C - Kymab | 100 M USD |